Hormone replacement therapy in menopausal women: Risk factor or protection to nonalcoholic fatty liver disease?
| Autor: | Andre Vinicius de Assis Florentino, Manoel Medeiros-Neto, Gesira Soares de Assis Florentino, Helma Pinchemel Cotrim, Paulo Adriano Schwingel, Consuelo Padilha, Gerson Bragagnoli |
|---|---|
| Předmět: |
medicine.medical_specialty
Cirrhosis Hepatology business.industry Fatty liver Specialties of internal medicine nutritional and metabolic diseases General Medicine medicine.disease digestive system Gastroenterology digestive system diseases Menopause Liver disease Endocrinology RC581-951 Transgender hormone therapy Internal medicine Nonalcoholic fatty liver disease medicine Steatosis Steatohepatitis business |
| Zdroj: | Scopus-Elsevier Europe PubMed Central Annals of Hepatology, Vol 11, Iss 1, Pp 147-149 (2012) |
| Popis: | Non-alcoholic fatty liver disease (NAFLD) represents a clinical condition that may progress from steatosis to steatohepatitis, cirrhosis and hepatocellular carcinoma. There are not enough information about the relationship between menopause and NAFLD, and this study evaluated the relevance of this liver disease in menopausal women (MPW), and the relationship between hormone replacement therapy (HTR) and NAFLD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|